Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Berger, Allison"'
Autor:
Zhang H; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Tomar VS; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Li J; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Basavaraja R; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Yan F; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Gui J; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., McBrearty N; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Costich TL; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Beiting DP; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Blanco MA; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Conejo-Garcia JR; Department of Immunology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Saggu G; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Berger A; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Nefedova Y; The Wistar Institute, Philadelphia, Pennsylvania., Gabrilovich DI; AstraZeneca, Gaithersburg, Maryland., Fuchs SY; Department of Biomedical Sciences, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2022 Dec 02; Vol. 10 (12), pp. 1490-1505.
Autor:
Bolleddula J; Takeda Development Center Americas, Inc., Lexington, Massachusetts swapan@bostonpharmaceuticals.com bolleddulajp@yahoo.com., Chen H; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Cohen L; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Zhou X; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Pusalkar S; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Berger A; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Sedarati F; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Venkatakrishnan K; Takeda Development Center Americas, Inc., Lexington, Massachusetts., Chowdhury SK; Takeda Development Center Americas, Inc., Lexington, Massachusetts swapan@bostonpharmaceuticals.com bolleddulajp@yahoo.com.
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2022 Jul; Vol. 50 (7), pp. 989-997. Date of Electronic Publication: 2022 May 03.
Autor:
Darabos K; Section on Behavioral Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Berger AJ; Section on Behavioral Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, USA., Ford JS; Hunter College and The Graduate Center, City University of New York, New York, NY, USA.
Publikováno v:
Journal of psychosocial oncology [J Psychosoc Oncol] 2022; Vol. 40 (4), pp. 457-472. Date of Electronic Publication: 2021 Apr 27.
Autor:
Darabos K; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Berger AJ; Children's Hospital of Philadelphia, Philadelphia, PA, USA., Barakat LP; Children's Hospital of Philadelphia, Philadelphia, PA, USA.; University of Pennsylvania, Philadelphia, PA, USA., Schwartz LA; Children's Hospital of Philadelphia, Philadelphia, PA, USA.; University of Pennsylvania, Philadelphia, PA, USA.
Publikováno v:
Qualitative health research [Qual Health Res] 2021 Nov; Vol. 31 (13), pp. 2355-2363. Date of Electronic Publication: 2021 Aug 12.
Autor:
Sarantopoulos J; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, Texas. Sarantopoulo@uthscsa.edu., Shapiro GI; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Cohen RB; Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Clark JW; MGH Cancer Center, Massachusetts General Hospital, Boston, Massachusetts., Kauh JS; Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Weiss GJ; Virginia G. Piper Cancer Center at Scottsdale Healthcare, Scottsdale, Arizona., Cleary JM; Early Drug Development Center, Dana-Farber Cancer Institute, Boston, Massachusetts., Mahalingam D; Institute for Drug Development, Cancer Therapy and Research Center at University of Texas Health Science Center, San Antonio, Texas., Pickard MD; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Faessel HM; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Berger AJ; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Burke K; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Mulligan G; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Dezube BJ; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited., Harvey RD; Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2016 Feb 15; Vol. 22 (4), pp. 847-57. Date of Electronic Publication: 2015 Sep 30.
Autor:
Smith DC; University of Michigan Comprehensive Cancer Center, 7302 CC SPC 5948, 1500 E. Medical Center Drive, Ann Arbor, MI, 48109-5948, USA, dcsmith@umich.edu., Kalebic T, Infante JR, Siu LL, Sullivan D, Vlahovic G, Kauh JS, Gao F, Berger AJ, Tirrell S, Gupta N, Di Bacco A, Berg D, Liu G, Lin J, Hui AM, Thompson JA
Publikováno v:
Investigational new drugs [Invest New Drugs] 2015 Jun; Vol. 33 (3), pp. 652-63. Date of Electronic Publication: 2015 Mar 18.
Autor:
Kupperman E; Millennium Pharmaceuticals, Inc., Cambridge, Massachusetts 02139, USA. erik.kupperman@mpi.com, Lee EC, Cao Y, Bannerman B, Fitzgerald M, Berger A, Yu J, Yang Y, Hales P, Bruzzese F, Liu J, Blank J, Garcia K, Tsu C, Dick L, Fleming P, Yu L, Manfredi M, Rolfe M, Bolen J
Publikováno v:
Cancer research [Cancer Res] 2010 Mar 01; Vol. 70 (5), pp. 1970-80. Date of Electronic Publication: 2010 Feb 16.
Autor:
Soucy TA; Discovery, Millennium Pharmaceuticals, Inc., 40 Landsdowne Street, Cambridge, Massachusetts 02139, USA. teresa.soucy@mpi.com, Smith PG, Milhollen MA, Berger AJ, Gavin JM, Adhikari S, Brownell JE, Burke KE, Cardin DP, Critchley S, Cullis CA, Doucette A, Garnsey JJ, Gaulin JL, Gershman RE, Lublinsky AR, McDonald A, Mizutani H, Narayanan U, Olhava EJ, Peluso S, Rezaei M, Sintchak MD, Talreja T, Thomas MP, Traore T, Vyskocil S, Weatherhead GS, Yu J, Zhang J, Dick LR, Claiborne CF, Rolfe M, Bolen JB, Langston SP
Publikováno v:
Nature [Nature] 2009 Apr 09; Vol. 458 (7239), pp. 732-6.